Filing Flows › Cannapharmarx (CPMD) › Q4 2024
Cannapharmarx (CPMD) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Apr 10, 2025
Cannapharmarx (CPMD) reported revenue of $482K for the fourth quarter 2024 (Q4 2024) and +54% from the quarter before. Operating margin was -316.9%, net loss $3.7M (775.9% of revenue).
Cannapharmarx, Q4 2024: revenue $482K, operating margin -316.9%, net loss $3.7M, operating cash flow −$180K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $482K | +54% | — |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$180K | — | — |
What changed
Revenue was $482K in Q4 2024, up 54% from the previous quarter.
Operating costs exceeded revenue by $1.5M, an operating margin of -316.9%. The quarter ended with a net loss of $3.7M, after a profit of $188K the previous quarter. Net interest and other expense of $2.2M was the main reason.
Operating cash flow was −$180K. Working capital and other items added $3.6M.
Questions
What was Cannapharmarx's revenue in the fourth quarter 2024?
Cannapharmarx (CPMD) reported revenue of $482K for the fourth quarter 2024 (Q4 2024) and +54% from the quarter before.
Was Cannapharmarx profitable in the fourth quarter 2024?
Operating loss was $1.5M (-316.9% of revenue) and net loss $3.7M.
Source: Cannapharmarx 10-K on SEC EDGAR.